Challenges of antithrombotic therapy in the management of cardiovascular disease in patients with inherited bleeding disorders: A single‐centre experience
Haemophilia2021Vol. 27(3), pp. 425–433
Citations Over TimeTop 23% of 2021 papers
Oliver Cohen, Michele Bertelli, Gavin Manmathan, Callum Little, Anne Riddell, Debra Pollard, Elsa Aradom, Molly Mussara, Chris F. Harrington, Pamela Kanagasabapathy, Ravi De Silva, Bruce Martin, Ana Rita Peralta, Keith Gomez, T. T. Yee, Pratima Chowdary, Roby Rakhit
Abstract
Our experience demonstrates the importance of interdisciplinary communication to identify strategies that decrease the risk of bleeding and thrombosis. The use of extended, increased intensity prophylaxis facilitated antiplatelet therapy. Global assays may help balance the intensity of haemostatic and antithrombotic treatment.
Related Papers
- → Underutilization of antithrombotic therapy in atrial fibrillation(2000)28 cited
- → Antithrombotic therapy in atrial fibrillation: aspirin is rarely the right choice(2013)13 cited
- → The Role of Aspirin After High-Risk Percutaneous Coronary Intervention(2020)1 cited
- → Primary and Secondary Stroke Prevention in Atrial Fibrillation(1998)4 cited
- Analysis of antithrombotic therapy in elderly patients with atrial fibrillation(2007)